ATE108906T1 - Methode zur bestimmung des verhaltens von medikamenten in lebewesen. - Google Patents

Methode zur bestimmung des verhaltens von medikamenten in lebewesen.

Info

Publication number
ATE108906T1
ATE108906T1 AT88115581T AT88115581T ATE108906T1 AT E108906 T1 ATE108906 T1 AT E108906T1 AT 88115581 T AT88115581 T AT 88115581T AT 88115581 T AT88115581 T AT 88115581T AT E108906 T1 ATE108906 T1 AT E108906T1
Authority
AT
Austria
Prior art keywords
drugs
animal
behavior
drug
determining
Prior art date
Application number
AT88115581T
Other languages
English (en)
Inventor
Hiroyuki Inst Of Bio-Ac Ohhara
- Kinashi Aza Kawakitaya Pharm
Akio Inst Of Bio-Act Namimatsu
Hirohide Inst Of Bio- Matsuura
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE108906T1 publication Critical patent/ATE108906T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88115581T 1987-09-22 1988-09-22 Methode zur bestimmung des verhaltens von medikamenten in lebewesen. ATE108906T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62238006A JPS6479657A (en) 1987-09-22 1987-09-22 Vital decision of medicine

Publications (1)

Publication Number Publication Date
ATE108906T1 true ATE108906T1 (de) 1994-08-15

Family

ID=17023739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88115581T ATE108906T1 (de) 1987-09-22 1988-09-22 Methode zur bestimmung des verhaltens von medikamenten in lebewesen.

Country Status (5)

Country Link
US (1) US4996988A (de)
EP (1) EP0308926B1 (de)
JP (1) JPS6479657A (de)
AT (1) ATE108906T1 (de)
DE (1) DE3850728T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6234965B1 (en) * 1998-03-31 2001-05-22 Scientific Learning Corporation Methods and apparatus for improving biochemical based therapy in humans
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
CN101528947A (zh) * 2006-09-06 2009-09-09 日本脏器制药株式会社 通过基因表达分析进行研究、判定或评价的方法
WO2011017835A1 (en) * 2009-08-11 2011-02-17 Nanjing University Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
CN115629217A (zh) 2013-04-30 2023-01-20 日本脏器制药株式会社 提取物和含有该提取物的制剂
US20150031004A1 (en) 2013-07-24 2015-01-29 Lumos Labs, Inc. Physically intuitive, real-time, multiple object tracking, planning and divided attention task for enhancing cognition
EP3733205A4 (de) * 2017-12-28 2021-12-08 Hyogo College Of Medicine Beschleuniger der produktion der synthase von lipocalin-typ-prostaglandin-d2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU506395A1 (ru) * 1974-06-10 1976-03-15 Всесоюзный научно-исследовательский институт ветеринарной санитарии Способ токсикологического исследовани м са животных, вынужденно забитых при фузариотоксикозе
SU656099A1 (ru) * 1977-09-06 1979-04-05 Научно-Исследовательский Институт Эпидемиологии, Микробиологии И Инфекционных Болезней Способ моделировани реакций клеточной гиперчувствительности
SU1076810A1 (ru) * 1981-05-29 1984-02-29 Институт питания АМН СССР Способ определени безвредности продуктов питани
US4537747A (en) * 1983-03-16 1985-08-27 Chemetrics, Inc. Disposable device for sampling and diluting
US4535786A (en) * 1983-07-25 1985-08-20 Kater John A R Measurement of body fluid chemistry
SU1187793A1 (ru) * 1984-01-31 1985-10-30 Do G Med I Im A M Gorkogo Способ диагностики острого панкреатита
US4677968A (en) * 1986-01-14 1987-07-07 University Of Utah Research Foundation Methods of testing the reaction of various substances on living human skin

Also Published As

Publication number Publication date
JPH0565106B2 (de) 1993-09-17
JPS6479657A (en) 1989-03-24
US4996988A (en) 1991-03-05
EP0308926A2 (de) 1989-03-29
EP0308926B1 (de) 1994-07-20
DE3850728D1 (de) 1994-08-25
DE3850728T2 (de) 1994-12-22
EP0308926A3 (en) 1990-07-11

Similar Documents

Publication Publication Date Title
DE69533942D1 (de) Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen
Hultén et al. Dynamics in serum of the inflammatory markers serum amyloid A (SAA), haptoglobin, fibrinogen and α2‐globulins during induced noninfectious arthritis in the horse
BR9908165A (pt) Processos de prevenção de um citotóxico de proteìna beta amilóide em células, de tratamento de uma fibrilogênica em um sujeito humano, de diminuição da oxidação em uma amostra biológica e de tratamento de doenças ou outros quadros em que radicais livres e/ou tensão oxidativa desempenham um papel, e, uso de ácido indol-3-propiÈnico ou um seu sal ou éster.
ES2124702T3 (es) Usos terapeuticos de compuestos que se unen a actina.
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
Virchenko et al. Independent and additive stimulation of tendon repair by thrombin and plateletss
Shytikov et al. Aged mice repeatedly injected with plasma from young mice: a survival study
ATE108906T1 (de) Methode zur bestimmung des verhaltens von medikamenten in lebewesen.
DE69110289T2 (de) Verabreichung von wirkstoffen zu wassertieren mittels überschallen.
ATE242005T1 (de) P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes
ATE537823T1 (de) Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin
Zbóril et al. S100B protein and neuron-specific enolase as predictors of postoperative cognitive dysfunction in aged dogs: a case-control study
Pai et al. Kinetics of aluminum in rats I: Dose‐dependent elimination from blood after intravenous administration
Mulvihill et al. An investigation of factors influencing the bioavailability of non-heam iron from meat systems
SE8701437D0 (sv) Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet
Smeller et al. A physiological study of immobilized cheetahs (Acinonyx jubatus)
Popiel et al. Antipruritic application of ovocystatin in atopic dermatitis in dogs-preliminary study
Dart et al. Effects of two large doses of equine recombinant growth hormone on clinical, haematological and serum biochemical variables in adult horses
Mößeler et al. NBT‐PABA test to assess efficiency and kinetics of substituted proteolytic enzyme action in pancreatic duct ligated minipigs
JPH0356719B2 (de)
Duckert Section 3 The absence of effect of the antirheumatic drug ibuprofen on Oral anticoagulation with phenprocoumon
Vallee Jr Some Aspects Of The Biochemistry And Physiology Of The Blood Of Ascidia Nigra
Tsarevskiĭ et al. Molecular aspects of the interaction between albumin and tannin-treated erythrocytes in the process of hemosensitization. Report 1. Stable and unstable effects. Quantitative parameters
Garland The practice laboratory—Part 2: biochemistry

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties